Original Research
Published on 12 Jul 2024
Comparing the adverse effects of ketamine and esketamine between genders using FAERS data
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1329436
- 1,481 views
Type at least 3 characters
396 articles
Articles
Original Research
Published on 10 Jul 2024
The real-world safety of oseltamivir and baloxavir marboxil in children: a disproportionality analysis of the FDA adverse event reporting system
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1391003
- 1,299 views
Original Research
Published on 04 Jul 2024
A disproportionality analysis of adverse events caused by GnRHas from the FAERS and JADER databases
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1392914
- 2,388 views
Original Research
Published on 03 Jul 2024
Falls in hospitalized older adults and the use of fall risk-increasing drugs and anticholinergic medications in Colombia: a case‒control study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1369200
- 1,142 views
Original Research
Published on 02 Jul 2024
Clinical adverse events to dexmedetomidine: a real-world drug safety study based on the FAERS database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1365706
- 1,535 views
Original Research
Published on 28 Jun 2024
Active monitoring of antifungal adverse events in hospitalized patients based on Global Trigger Tool method
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1322587
- 580 views
Original Research
Published on 27 Jun 2024
Delabelling beta-lactam allergy
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1423719
- 1,367 views
Original Research
Published on 26 Jun 2024
Statin use and fall risk in adults: a cross-sectional survey and mendelian randomization analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1364733
- 2,498 views
- 1 citation
Original Research
Published on 24 Jun 2024
Pulmonary haemorrhage and haemoptysis associated with bevacizumab-related treatment regimens: a retrospective, pharmacovigilance study using the FAERS database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1339505
- 1,172 views
- 1 citation
Original Research
Published on 20 Jun 2024
Effect of ultrashort-acting β-blockers on 28-day mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a meta-analysis of randomized controlled trials and trial sequential analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1380175
- 988 views
Original Research
Published on 20 Jun 2024
Consumer awareness and knowledge regarding use of non-steroidal anti-inflammatory drugs (NSAIDs) in a metropolitan area
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1362632
- 1,587 views
Original Research
Published on 14 Jun 2024
Hepatitis-related adverse events associated with immune checkpoint inhibitors in cancer patients: an observational, retrospective, pharmacovigilance study using the FAERS database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1383212
- 1,471 views
- 1 citation
Original Research
Published on 14 Jun 2024
Risk of immune system and skin and subcutaneous tissue related adverse events associated with oxaliplatin combined with immune checkpoint inhibitors: a pharmacovigilance study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1309540
- 928 views
Systematic Review
Published on 12 Jun 2024
An overview and single-arm meta-analysis of immune-mediated adverse events following COVID-19 vaccination
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1308768
- 1,317 views
Original Research
Published on 12 Jun 2024
The prevalence of polypharmacy and hyper-polypharmacy among middle-aged vs. older patients in Saudi Arabia: a cross-sectional study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1357171
- 1,669 views
- 3 citations
Original Research
Published on 12 Jun 2024
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1403093
- 912 views